IRB Number:

05-004060

Trial Status:

Open for Enrollment

Phase: IV

Why is this study being done?

This study is being done to compare the effects of two drugs for the treatment of type 2 diabetes. This study will evaluate the effects of adding exenatide, rosiglitazone, or both to your current oral antidibetic medication (metformin). The study will evaluate the effects of these medications on beta cell function, insulin sensitivity, blood glucose control and body weight.

Who is Eligible to Participate in the Study?

Volunteers with Type 2 diabetes currently on treatment with metformin alone.

Minimum Age:

18

Maximum Age:

75

What is Involved With this Study?

10 out-patient visits to Saint Marys Hospital Clinical Research Unit (CRU).

How long will the Study run?

26 weeks

Who can I Contact for Additional Information on this Trial?

Paula Giesler RN CDE 507-255-8345
Adrian Vella MD 507-255-0491

What is/are the Locations of this Clinical Trial?

• Rochester, MN

Last updated: 04/07/2008